Sg3 Management, LLC Rapt Therapeutics, Inc. Transaction History
Sg3 Management, LLC
- $0
- Q3 2023
Shares
2 transactions
Others Institutions Holding RAPT
# of Institutions
103Shares Held
49.4MCall Options Held
26.7KPut Options Held
2.4K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$25.5 Million7.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.16MShares$3.6 Million0.0% of portfolio
-
Column Group LLC San Francisco, CA2.68MShares$3.06 Million7.75% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$2.78 Million0.0% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY1.73MShares$1.97 Million0.42% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $33.8M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...